D'Alessandro Danilo 4
4 · ClearPoint Neuro, Inc. · Filed Nov 25, 2025
Insider Transaction Report
Form 4
D'Alessandro Danilo
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2025-11-21$8.10/sh+3,555$28,796→ 69,923 total - Exercise/Conversion
Stock Options (right to buy)
2025-11-21−3,555→ 12,082 totalExercise: $8.10Exp: 2033-03-06→ Common Stock (3,555 underlying)
Footnotes (2)
- [F1]Mr. D'Alessandro paid the exercise price for the option in cash and has held all shares received upon exercise. No shares of stock were sold in connection with this transaction.
- [F2]The shares subject to this option vest as follows: (i) 20% of the total shares on the first anniversary of the grant date; (ii) 40% of the total shares on the second anniversary of the grant date; and (iii) 40% of the total shares on the third anniversary of the grant date. The grant date is March 6, 2023.